ISU ABXIS is a biotechnology company dedicated to the development of new and novel bio-therapeutics that will enhance the lives and ease the suffering of patients struggling with cancer and rare diseases...
ISU ABXIS is focused on the development of innovative antibody-based therapeutics that target significant unmet medical needs in oncology and rare diseases...
ISU ABXIS is pioneering the discovery of engineered antibody-based immunotherapy to target tumors and rare diseases. Our technology advances in antibody-based platform for the treatment of human disease.